FIELD: medicine.
SUBSTANCE: invention can be used for correction of disorders occurring in arterial hypertension (AH) and obesity. Method of patient's condition correction by arterial hypertension and obesity includes base therapy enalapril in amount of 2.5–10 mg a day in combination with application of biologically active additive, containing trecresan, beta-carotene, alpha-tocopherol, garlic and lactose as a hypolipidemic agent in amount of 100–200 mg 2 times day for 21 days, two courses for 6 months, in the first and fourth months of treatment.
EFFECT: invention provides reducing blood pressure, improving lipid spectrum and reducing side effects in patients with arterial hypertension and obesity.
1 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PATIENTS WITH OBESITY AND ARTERIAL HYPERTENSION STATE CORRECTION | 2019 |
|
RU2729352C1 |
| TRECRESAN APPLICATION FOR TREATING PATIENTS SUFFERING ARTERIAL HYPERTENSION AND OBESITY | 2010 |
|
RU2429832C1 |
| METHOD FOR PREDICTING ENALAPRYL EFFICIENCY IN TREATING HYPERTENSION DISEASE PATIENTS IN RUSSIAN PEOPLE POPULATION | 2006 |
|
RU2305837C1 |
| METHOD FOR CORRECTING COGNITIVE DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION ACCOMPANYING TYPE 2 DIABETES MELLITUS | 2014 |
|
RU2555334C1 |
| METHOD OF COMPLEX THERAPY OF OBESITY IN PATIENTS WITH ARTERIAL HYPERTENSION | 2015 |
|
RU2607186C1 |
| METHOD FOR CORRECTING INCREASED LEVELS OF ANXIETY AND DEPRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION ACCOMPANYING TYPE 2 DIABETES MELLITUS | 2014 |
|
RU2554806C1 |
| METHOD FOR TREATING PAIN-FREE MYOCARDIAL ISCHEMIA IN PATIENTS WITH CHRONIC OBSTRUCTIVE BRONCHITIS | 2003 |
|
RU2266112C2 |
| PREPARATION MODULATING FERRITIN CONCENTRATION IN BLOOD SERUM | 2020 |
|
RU2749347C1 |
| METHOD FOR LEFT VENTRICULAR HYPERTROPHY CORRECTION IN ELDERLY AND SENILE PATIENTS WITH ARTERIAL HYPERTENSION | 2014 |
|
RU2568902C2 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING PATIENTS AT HYPERTONIC DISEASE AND OBESITY WITH LYSINOPRIL | 2004 |
|
RU2289300C2 |
